EyePoint Pharmaceuticals Announces Closing of $115.4 Million Public Offering
WATERTOWN, Mass., Nov. 19, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced the closing of the previously…